What can HIV vaccine trials teach us about future HIV vaccine dissemination?
about
Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesEffect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionEnhancing HIV vaccine trial consent preparedness among street drug usersHIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation."Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Engaging members of African American and Latino communities in preventive HIV vaccine trials.Social and behavioral science in HIV vaccine trials: a gap assessment of the literature."Like Holding an Umbrella Before It Rains": Acceptability of Future Rectal Microbicides Among Men Who Have Sex With Men in India-A Modified Technology Acceptance Model.Typologies of Altruistic and Financial Motivations for Research ParticipationIntegrating social and biomedical science in HIV vaccine research: obstacles, opportunities and ways forward.Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.Acceptability and Preferences for Hypothetical Rectal Microbicides among a Community Sample of Young Men Who Have Sex with Men and Transgender Women in Thailand: A Discrete Choice Experiment."Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.Immune to addiction: the ethical dimensions of vaccines against substance abuse.'Why would you promote something that is less percent safer than a condom?': Perspectives on partially effective HIV prevention technologies among key populations in South AfricaA social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand
P2860
Q27005602-48960DD3-76EA-4483-AA82-87D6C9B6EAAEQ30206105-6DE2E471-F731-4EF0-9121-E45A9B7F9276Q30227101-189839D0-842E-41FA-B7A9-D72A5BDB93E5Q33786360-A5D4D795-50B2-4027-977D-ED5EAB6C3098Q34123592-9C25F0F9-5CE6-4AB9-BE43-24A5009C99A9Q35219438-C4439284-A05D-4468-B87F-1AC499554054Q35301155-B092E7E9-6E88-46A9-B681-C67C958FEDFEQ35736408-A9EC9A5D-89BE-41DF-AAA7-61FC26E9A395Q37386288-8DE7BCCF-76FD-49DD-BF84-568645E5467EQ38662018-93275CE6-2CD0-4857-8547-ACD90240CCB8Q41647548-162A9BAC-4A55-4902-870F-4893B5FB6DBEQ44428535-F45B024B-494B-4D5C-9426-434550A941E0Q45365760-72DDE9A0-F6EF-4536-9AB8-B458CF43B62AQ50114646-A7C9BDCC-7BE6-478A-A502-093D75A33104Q50135709-1D61EED9-8D83-4460-A5EC-088D3CA1A2F6Q51692824-82102796-8DB5-492F-9637-321F917C9E7EQ52300855-65D7D870-0435-4E41-BB64-10ABEB25D041Q58452343-27161157-723A-4512-8035-32B77589F3AEQ58452373-DC923E12-5E0B-4BF9-9B20-18347E8FA4B0
P2860
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@en
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@nl
type
label
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@en
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@nl
prefLabel
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@en
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@nl
P2093
P2860
P1433
P1476
What can HIV vaccine trials teach us about future HIV vaccine dissemination?
@en
P2093
Kathleen Roberts
Lisa Kakinami
Naihua Duan
P2860
P304
P356
10.1016/J.VACCINE.2008.03.004
P407
P577
2008-03-28T00:00:00Z